Advertisement

Indian Pediatrics

, Volume 56, Issue 10, pp 845–848 | Cite as

Serum Folate Levels in Patients with Chronic Hemolytic Anemia on Regular Folic Acid Supplementation Before and After Dose Modification

  • Mona AzzamEmail author
  • Samy Attalla
Research Paper
  • 10 Downloads

Abstract

Objective

In light of the recommendation of folic acid supplementation in chronic hemolytic anemia, with possible supratherapeutic dosing and associated side effects, we performed this study to investigate serum folate levels in children with chronic hemolytic anemia.

Methods

Phase 1 was a cross-sectional study of 134 patients in the Pediatric Hematology service, documenting daily dosage and performing serum folate levels. In phase 2, we reduced the dose to 1 mg for 148 patients and repeated the testing after six months.

Results

We found very high serum folate levels with Phase 1, with 93.2% above the upper level of normal. In Phase 2, values remained high with 42.5% above the acceptable upper limit.

Conclusions

Doses of folic acid given to sickle cell and thalassemia patients exceed their actual needs. This should be re-evaluated to strike a balance between benefit and harm, with close monitoring of serum folate levels.

Keywords

Harm Sickle cell anemia Supplementation Thalassemia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

Funding: None; Competing Interest: None stated.

References

  1. 1.
    Hazra A, Tripathi SK. Folic acid revisited. Indian J Pharmacol. 2001;33:322–42.Google Scholar
  2. 2.
    Kennedy TS, Fung EB, Kawchak DA, Zemel BS, Ohene-Frempong K, Stallings VA. Red blood cell folate and serum vitamin B12 status in children with sickle cell disease. J Pediatr Hematol Oncol. 2001;23:165–9.CrossRefGoogle Scholar
  3. 3.
    Liu YK. Folic acid deficiency in sickle cell anaemia. Scand J Haematol. 1975;14:71–9.CrossRefGoogle Scholar
  4. 4.
    van der Dijs FP, Schnog JJ, Brouwer DA, Velvis HJ, van den Berg GA, Bakker AJ, et al. Elevated homocysteine levels indicate suboptimal folate status in pediatric sickle cell patients. Am J Hematol. 1998;59:192–8.CrossRefGoogle Scholar
  5. 5.
    Dixit R, Nettem S, Madan SS, Soe HHK, Abas AB, Vance LD, et al. Folate supplementation in people with sickle cell disease. Cochrane Database Syst Rev. 2018;3:CD011130.PubMedGoogle Scholar
  6. 6.
    Fischbach F, Dunning MB. Manual of Laboratory and Diagnostic Tests. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2008.Google Scholar
  7. 7.
    Gall S, Seal J, Taylor R, Dwyer T, Venn A. Folate status and socio-demographic predictors of folate status, among a national cohort of women aged 26–36 in Australia, 2004–2006. Aust N Z J Public Health. 2012;36:421–6.CrossRefGoogle Scholar
  8. 8.
    Matsuzaki M, Haruna M, Ota E, Sasaki S, Nagai Y, Murashima S. Dietary folate intake, use of folate supplements, lifestyle factors, and serum folate levels among pregnant women in Tokyo, Japan. J Obstet Gynaecol Res. 2008;34:971–9.PubMedGoogle Scholar
  9. 9.
    Dhar M, Bellevue R, Carmel R. Pernicious anemia with neuropsychiatric dysfunction in a patient with sickle cell anemia treated with folate supplementation. N Engl J Med. 2003;348:2204–7.CrossRefGoogle Scholar
  10. 10.
    Smith AD, Kim Y, Refsum Y. Is folic acid good for everyone? Am J Clin Nutr. 2008;87:517–33.CrossRefGoogle Scholar
  11. 11.
    Conley CL, Krevans JR. Development of neurologic manifestations of pernicious anemia during multivitamin therapy. N Engl J Med 1951;245:529–31.CrossRefGoogle Scholar
  12. 12.
    Rosenberg IH. Science-based micronutrient fortification: which nutrients, how much, and how to know? Am J Clin Nutr. 2005;82:279–80.CrossRefGoogle Scholar
  13. 13.
    Claster S, Wood JC, Noetzli L, Carson SM, Hofstra TC, Khanna R, et al. Nutritional deficiencies in iron overloaded patients with hemoglobinopathies. Am J Hematol. 2009;84:344–8.CrossRefGoogle Scholar
  14. 14.
    Kim YI. Does a high folate intake increase the risk of breast cancer? Nutr Rev. 2006;64:468–75.CrossRefGoogle Scholar
  15. 15.
    Kim SJ, Zuchniak A, Sohn KJ, Lubinski J, Demsky R, Eisen A, et al. Plasma folate, vitamin B-6, and vitamin B-12 and breast cancer risk in BRCA1- and BRCA2-mutation carriers: A prospective study. Am J Clin Nutr. 2016;104:671–7.CrossRefGoogle Scholar
  16. 16.
    Tomaszewski JJ, Cummings JL, Parwani AV, Dhir R, Mason JB, Nelson JB, et al. Increased cancer cell proliferation in prostate cancer patients with high levels of serum folate. Prostate. 2011;71:1287–93.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Castillo-L C, Tur JA, Uauy R. Folate and breast cancer risk: A systematic review. Rev Med Chil. 2012;140:251–60.CrossRefGoogle Scholar
  18. 18.
    Venn BJ, Mann JI, Williams SM, Riddell LJ, Chisholm A, Harper MJ, et al. Assessment of three levels of folic acid on serum folate and plasma homocysteine: A randomised placebo-controlled double-blind dietary intervention trial. Eur J Clin Nutr. 2002;56:748–54.CrossRefGoogle Scholar
  19. 19.
    Pena AS, Maftei O, Dowling K, Gent R, Wiltshire E, MacKenzie K, et al. Folate fortification and supplementation do not provide vascular health benefits in type 1 diabetes. J Pediatr. 2013;163:255–60.CrossRefGoogle Scholar
  20. 20.
    Nguyen GT, Lewis A, Goldener C, Reed B, Dulman RY, Yang E. Discontinuation of folic acid supplementation in young patients with sickle cell anemia. J Pediatr Hematol Oncol. 2017;39:470–2.CrossRefGoogle Scholar

Copyright information

© Indian Academy of Pediatrics 2019

Authors and Affiliations

  1. 1.Pediatric Department, Faculty of MedicineSuez Canal UniversityIsmailiaEgypt
  2. 2.Medical laboratory DepartmentKing Fahad Armed Forces HospitalJeddahSaudi Arabia

Personalised recommendations